LCN2 and heart disorder: In patients with cardiac diseases or undergoing cardiovascular surgery, new markers of renal dysfunction, such as neutrophil gelatinase-associated lipocalin (NGAL) [18–21] and cystatin C [22–26], have emerged as early markers of AKI prior to any elevations of serum creatinine and have been shown to provide additional prognostic capacity in these settings.